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Neospora caninum is a coccidial protozoan parasite that appears morphologically indistinguishable from
Toxoplasma gondii and that infects a large range of mammals. Both inbred and outbred strains of mice exhibit
a high degree of resistance to infection with N. caninum. Three inbred strains of mice (A/J, BALB/c, and
C57BL/6) that were infected intraperitoneally with N. caninum were protected against a lethal challenge from
T. gondii. Vaccine-induced protection was Neospora dose dependent. A rise in the CD81 T-cell population in
mice that had been vaccinated with N. caninum and challenged with T. gondii was observed. Adoptive transfer
of CD81 T-cell splenocytes from N. caninum-infected mice was protective against challenge with Toxoplasma.
The CD81 T cells from Neospora-infected mice proliferate to both Neospora and Toxoplasma antigens in vitro
and secrete substantial quantities of gamma interferon when pulsed with the parasite antigen. These obser-
vations demonstrate that N. caninum protects against lethal T. gondii infection by the induction of CD81 T cells
that are immunoreactive to both parasites.
Neospora caninum is a recently described parasite belonging
to the Apicomplexa that has been reported to infect a wide
range of mammals, although human infection has not yet been
described. Infection with this parasite causes a variety of clin-
ical disorders including severe transplacentally acquired neu-
rologic disease in dogs (2, 20). Neospora infection has been
observed in other domestic animals (6) and in livestock (1, 5),
where it is considered to be an important pathogen in causing
abortion. In mice, N. caninum is able to induce clinical infec-
tion, producing such diseases as primary pneumonia, myositis,
encephalitis, radiculoneuritis, and pancreatitis (18).
Although N. caninum and Toxoplasma gondii are morpho-
logically similar, they are genetically distinct (19) and probably
divergent (8). There is considerable antigenic distinction be-
tween these two parasite species. In particular, Neospora lacks
both major Toxoplasma surface proteins, SAG1 (p30) and
SAG2 (p22) (4). While the host immune response to Toxo-
plasma has been well studied, only recently have the mecha-
nisms of immunity to Neospora been analyzed. In vitro obser-
vations suggest that gamma interferon (IFN-g) may be
involved in host immunity (11). Recently we have reported that
mice are highly resistant to infection with large numbers (106
or more) of N. caninum tachyzoites. T cells from Neospora-
infected mice proliferate in response to Toxoplasma antigen.
Both interleukin 12 (IL-12) and IFN-g appear to be important
modulators of immunity to this parasite since inhibition of
either of these cytokines significantly increases mouse suscep-
tibility to infection (17).
A variety of approaches have been attempted to develop an
effective vaccine against Toxoplasma. Earlier studies utilizing
vaccines made from killed (e.g., by heat or formalin) organisms
(12) have been unsuccessful in producing effective host immu-
nity. Those studies have shown that partial protection was
obtainable but that complete protection against challenge with
even an avirulent parasite was not possible. Alternative ap-
proaches using either attenuated parasites (13) or the temper-
ature-sensitive mutant (ts-4) (21) have produced resistance
against virulent parasite challenge (9).
Immunity to T. gondii is dependent upon the early produc-
tion of IFN-g and CD81 T cells. CD81 T cells are considered
to be major effector cells responsible for protection against T.
gondii (reviewed in reference 13). Isolated CD81 T cells ex-
hibit cytotoxic activity in vitro against parasite-infected macro-
phages (9). CD81 T cells obtained from ts-4-immunized mice
are cytotoxic for the T. gondii-infected P815 mastocytoma cell
line (23). Depletion of the CD81 population but not the CD41
population reduces the cytotoxic T-lymphocyte activity. CD81
T cells secrete IFN-g when stimulated with the parasite anti-
gen. Both of these antimicrobial functions may be essential
since neutralization of either IFN-g or CD81 T cells reverses
protection. Mice vaccinated with the ts-4 mutant strain of T.
gondii develop a strong protective response against subsequent
challenge with a virulent RH strain. The immunity stimulated
by this mutant can be adoptively transferred with CD81 T
cells. We have described an antigen-specific, cytotoxic T-cell
response against T. gondii. In vivo, CD81 T cells from mice
immunized with SAG1 (p30), the major surface antigen of T.
gondii, confer 100% protection against lethal parasite chal-
lenge. SAG1-specific CD81 T-cell clones protect against T.
gondii infection (15).
In this paper, we demonstrate that vaccination of mice with
intact N. caninum protects mice against a lethal challenge from
T. gondii. This protection is mediated by antigen-cross-reactive
CD81 T cells obtained from the spleens of N. caninum-vacci-
nated mice.
MATERIALS AND METHODS
Mice and parasites. Five- to six-week-old female A/J, C57BL/6, and BALB/c
mice were used for these studies (Jackson Laboratory, Bar Harbor, Maine). All
studies were carried out with A/J mice except as otherwise noted in the text or
legends. The NC-1 strain of N. caninum (kindly provided by David Lindsey,
Auburn University) was used for vaccination. All challenge experiments were
carried out 1 month postvaccination unless otherwise noted in the text or leg-
ends. Challenge experiments were performed with either the moderately virulent
type II (10) PLK strain (clonally derived from Me49) or the more-virulent type
I (10) RH strain of T. gondii. Both parasites were maintained by regular serial
passage in human foreskin fibroblasts.
Phenotypic analysis. Splenocytes were analyzed for cell phenotype by flow
cytometric analysis using an direct immunofluorescence assay. The homogenized
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splenocytes (106/ml) were incubated with 1 mg of fluorescein isothiocyanate
(FITC)-labeled anti-CD41, anti-CD81, anti-gd (Pharmingen, San Diego, Calif.),
or anti-NK cell (antiasailo GM1) rabbit polyclonal antibody. For the rabbit
antibody, indirect labelling was done with FITC-conjugated anti-rabbit immu-
noglobulin G (IgG) as the second reagent (Sigma Chemical Co., St. Louis, Mo.).
After incubation on ice for 45 min, the cells were washed in cold 3% phosphate-
buffered saline–bovine serum albumin, fixed with 2% paraformaldehyde, and
analyzed by fluorescence-activated cell sorter (FACS) scan.
Lymphoproliferation assay. Mice were infected with 106 tachyzoites of N.
caninum, and 14 days later their splenocytes were isolated. Purified CD81 T cells
were obtained from this population with magnetic beads (see below). The puri-
fied CD81 T cells were cultured in 96-well plates at the concentration of 105 cells
per well in a 200-ml volume. The cells were stimulated with 5 mg of concanavalin
A (Con A; Sigma Chemical Co.) or 15 mg of parasite lysate per ml. Parasite lysate
was prepared by sonication of 108 Percoll gradient-purified parasites. The son-
icate was centrifuged at 2,500 3 g, and the supernatant was measured for protein
content and used at a concentration of 15 mg/ml. Feeder cells were prepared by
using irradiated (3,000 rads) splenocytes from syngenic mice at a concentration
of 5 3 105 irradiated feeder cells per well. After 72 h the cells were pulse labeled
with tritiated thymidine (0.5 mCi/well; Amersham, Arlington Heights, Ill.) for
8 h. The cells were harvested on a glass filter by an automated multiple-cell
harvester, and the incorporation of radioactive thymidine was determined by
liquid scintillation.
Purification of CD81 T cells and adoptive transfer. Mice were vaccinated with
106 N. caninum tachyzoites. One month after vaccination, the CD81 T cells from
the infected and naive mice were isolated. Splenocytes were homogenized, and
contaminating erythrocytes were lysed in buffer (Sigma Chemical Co.). For
isolation of the CD81 T-cell subset, a magnetic bead cell sorter column was used
(Miltenyl Biotech, Auburn, Calif.). The cells were incubated with anti-CD81
monoclonal antibody according to the manufacturer’s instructions. Both CD81-
enriched and -depleted fractions were collected. The CD81 population was
.95% pure as determined by FACS. Next, 107 cells from the CD81-enriched
and -depleted fractions were used to adoptively vaccinate naive mice via tail vein
inoculation. Twenty four hours later the vaccinated mice were challenged with
104 PLK strain tachyzoites. The mice were observed daily for morbidity or
mortality until the experiment was terminated at day 21 postchallenge.
Cytokine analysis. For cytokine mRNA expression, splenocytes were obtained
from mice at 4-day intervals postvaccination with N. caninum (from days 1 to 21)
and postinfection with T. gondii (from day 1 until death). For vaccination studies,
mice were first vaccinated with 106 N. caninum tachyzoites and 7 days later were
challenged with a 100% lethal dose of T. gondii PLK (5 3 104 tachyzoites) via
intraperitoneal inoculation. Beginning at day 1 postchallenge and continuing
every fourth day through day 21 when the experiment was terminated, the
splenocytes were collected and cytokine mRNA levels were determined as pre-
viously described (14, 17). Briefly, total RNA was extracted with TRIzol (Be-
thesda Research Laboratories) and reverse transcription was performed with
random hexamer primers (Promega, Madison, Wis.). The determination of cy-
tokine production was made by quantitative PCR. Aliquots of cDNA were
assayed for IFN-g and IL-10 by examining the competitor-to-wild-type band
intensity ratio following amplification of each primer set. Separation of the PCR
products was done by electrophoresis on a 3% agarose gel. The splenocytes from
uninfected mice were used to establish a baseline value of 1.0 against which the
levels of mRNA for the cytokines in the test mice were quantitated. The data are
presented as a graph rather than as individual PCR gels for clarity. The assay for
the protein concentration of IFN-g was performed with a commercially prepared
kit (Endogen, Cambridge, Mass.) in accordance with the manufacturer’s instruc-
tions.
Western blot analysis. Western blot analysis was performed with either Neo-
spora or Toxoplasma lysate antigen (50 mg of protein/lane). The proteins were
separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and
transferred to nitrocellulose paper. For T-cell Western blotting, the nitrocellu-
lose paper was cut into 1-cm-wide strips and placed into a 96-well plate (in
triplicate). The wells were treated with 1% azide–saline for 1 h followed by
extensive rinsing in saline. Purified CD81 T cells from N. caninum-vaccinated
mice (105) were added to each well in the presence of irradiated feeder cells (5 3
105) obtained from the spleen cells of a naive host. After incubation for 5 days
the wells were harvested and DNA synthesis was measured as described above.
For antibody Western blotting, the nitrocellulose strips containing the trans-
ferred proteins were incubated with anti-Neospora polyclonal antibody. This
antibody was raised in rabbits by immunization with the equivalent of 5 3 107
purified N. caninum parasites/dose (17). Rabbits were immunized twice per week
over a 3-week period. The first immunization was done in the presence of
Freund’s complete adjuvant. The third and sixth immunizations were done with
Freund’s incomplete adjuvant, and the remainder of the immunizations were
done with parasite antigen alone. Rabbits were bled 2 weeks after the final
immunization, and their sera were pooled. The IgG fraction was purified from
the sera by protein A affinity, and the protein concentration was standardized
with a Bio-Rad system. Alternatively, sera were obtained from N. caninum-
infected mice and used for Western blotting.
RESULTS
N. caninum protects against acute infection with T. gondii.
Three inbred strain of mice (C57BL/6, A/J, and BALB/c) were
infected via intraperitoneal inoculation with N. caninum at 106
tachyzoites/mouse. One month later the mice were challenged
with tachyzoites of the PLK strain of T. gondii. None of the N.
caninum-vaccinated mice demonstrated clinical evidence of
infection (ruffled fur, weight loss, huddling). As shown in Fig.
1, all of the vaccinated mice survived the infection, in contrast
to nonvaccinated control mice, which died between days 8 and
10 after Toxoplasma challenge. There was no significant dif-
ference in time to death among the three inbred strains inoc-
ulated with a lethal challenge dose of Toxoplasma. Protection
persists for at least 3 months postchallenge, at which point the
study was terminated.
A time course study was performed to evaluate when after
immunization the mice developed resistance to challenge with
T. gondii. For this study, mice were vaccinated with N. caninum
and challenged at 7, 14, and 30 days postvaccination with a
lethal dose of T. gondii. All mice were completely protected
against challenge with Toxoplasma (data not shown) beginning
at day 7 postvaccination. A dose-dependent study was done to
determine the number of Neospora tachyzoites required to
protect against acute challenge with Toxoplasma. Mice were
vaccinated with increasing numbers of viable Neospora
tachyzoites. Protection against challenge with Toxoplasma was
dependent upon the number of Neospora tachyzoites in the
vaccination (Fig. 2). Mice vaccinated with 106 or more Neo-
spora tachyzoites were 100% protected, whereas mice receiving
fewer parasites were less well protected. Mice vaccinated with
5 3 104 Neospora tachyzoites were as susceptible as the non-
vaccinated control group.
To determine if protection was dependent upon the strain
and number of Toxoplasma tachyzoites used in the challenge,
mice were first vaccinated with the protective dose of Neospora
(106 tachyzoites). Postvaccination, the mice were challenged
FIG. 1. Survival of mice vaccinated with N. caninum against lethal T. gondii
challenge. Inbred A/J, BALB/c, and C57BL/6 mice were vaccinated via the
intraperitoneal (i.p.) route with 106 tachyzoites of N. caninum. After Neospora
vaccination the mice were challenged i.p. with a 90% lethal dose of T. gondii PLK
tachyzoites (open symbols). Control mice were not vaccinated but were infected
with T. gondii (solid symbols). The mice were observed daily for morbidity and
mortality. Results are representative of two experiments (n 5 12 mice/group).
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with either the PLK or RH strain of T. gondii. When the PLK
strain was used, mice became increasingly susceptible to Tox-
oplasma infection as the challenge dose increased. Complete
protection was observed when the challenge inoculum of PLK
strain parasites was at or below 105. A similar experiment using
the highly virulent RH strain as the challenge was performed.
In that experiment .75% survival was observed when the
challenge dose was 5 3 102 tachyzoites of T. gondii RH. Above
2 3 103 RH strain parasites, the mice were as susceptible as
nonvaccinated controls (data not shown).
CD81 T cells from Neospora-infected mice are protective. A
phenotypic analysis was carried out to evaluate the shift in
immune cell subsets following parasite exposure. Mice were
vaccinated with N. caninum (106 tachyzoites), followed by chal-
lenge with T. gondii PLK (104 tachyzoites). Seven days follow-
ing challenge (Table 1), increased expression of the CD81 and
NK cell populations was observed in all test conditions, most
notably with both vaccination and challenge. Also noted was
the dramatic rise in the gd T-cell population following expo-
sure to either T. gondii alone or to both parasites, but not to N.
caninum alone. There was a significant decrease in the CD41
T-cell population in response to parasite infection.
An adoptive-transfer experiment was performed to deter-
mine whether the splenocytes from vaccinated mice were able
to immunize naive mice against Toxoplasma challenge. For this
study (Fig. 3), mice were first vaccinated with Neospora (106
tachyzoites). One month later the isolated T cells (CD81 and
CD82) were adoptively transferred by tail vein injection into
naive mice and the mice were challenged with T. gondii PLK
tachyzoites (104). Mice receiving either CD81 T cells or whole
splenocytes from Neospora-vaccinated mice were protected
against Toxoplasma challenge (P , 0.001), whereas none of the
controls, including CD81 T cells from nonvaccinated mice and
the residual CD82 splenocyte population from the vaccinated
mice, were protective.
A lymphocyte DNA synthesis assay was performed to deter-
mine the antigen specificity of the CD81 T-cell response. The
CD81 T cells from vaccinated mice were cultured in the pres-
ence of either a mitogen (Con A) or parasite antigen. As
shown in Fig. 4, CD81 T cells from Neospora-vaccinated mice
were able to proliferate in vitro in response to both Neospora
and Toxoplasma antigen preparations. There was no significant
difference in the abilities of the lysates to induce parasite
antigen-specific proliferation.
The parasite antigen specificity of the CD81 T cells was
further supported by an adoptive-transfer study. For this study,
CD81 T cells were isolated from Neospora-vaccinated mice 1
month postimmunization and cultured in the presence of the
Toxoplasma antigen. Five days postculture, the CD81 T cells
were recovered (.98% purity as determined by FACS) and
adoptively transferred via tail vein injection into naive mice.
The adoptively immunized mice were challenged with T. gondii
(Fig. 5). The CD81 T cells from the Neospora-vaccinated mice
were protective against Toxoplasma challenge, whereas naive
CD81 T cells stimulated with antigen were nonprotective.
N. caninum modifies host cytokine response to T. gondii. A
quantitative PCR was performed to determine the level of
cytokine mRNA expression in mice following infection with
FIG. 2. Protection by N. caninum vaccination is dose dependent. A/J mice
were vaccinated with 106, 5 3 105, or 5 3 104 tachyzoites of N. caninum.
Postvaccination the mice were challenged with 2.5 3 104 PLK strain tachyzoites
of T. gondii via intraperitoneal inoculation. Control mice were sham vaccinated
with saline. Mice were examined daily for evidence of clinical infection, and
mortality was used as the end point. Results are representative of two experi-
ments (n 5 12 mice/group).
FIG. 3. CD81 T cells mediate protective immunity. A/J mice were vaccinated
with 106 tachyzoites of N. caninum. Postvaccination, their splenocytes were
isolated and separated with magnetic beads into a purified CD81 population.
Approximately 107 splenocytes were transferred directly into naive recipient
mice via tail vein inoculation. Control mice received an equivalent number of
spleen cells from saline-treated mice. Twenty-four hours after transfer the mice
were challenged with 104 PLK strain tachyzoites. Results are representative of
two experiments (n 5 12 mice/group).
TABLE 1. Phenotypic analysis of splenocytes postvaccination
and postchallengea
Treatment
Absolute no. of cells of indicated
cell type (107) 6 SD
CD4 CD8 gd NK
Saline 1.5 6 0.04 0.85 6 0.03 0.16 6 0.02 0.17 6 0.04
Neospora 1.62 6 0.08 1.49 6 0.09 0.15 6 0.04 0.65 6 0.05
Toxoplasma 0.92 6 0.03 1.12 6 0.17 1.32 6 0.04 0.75 6 0.14
Neospora 1 Toxoplasma 1.64 6 0.05 2.0 6 0.33 1.25 6 0.06 0.96 6 0.11
a Mice were infected with 106 N. caninum tachyzoites and challenged with 104
PLK strain tachyzoites of T. gondii. Phenotypic expression of CD4, CD8, gd, and
NK cells was determined either at the time of challenge (14 days postinfection
with Neospora) or 7 days after Toxoplasma challenge. n 5 4 mice/group.
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either Neospora, Toxoplasma, or both. Splenocytes from in-
fected mice were collected at different time intervals postvac-
cination or postchallenge, and mRNA expression was mea-
sured and IFN-g and IL-10 levels were determined. The level
of mRNA for IFN-g increased in mice vaccinated with Neo-
spora and infected with Toxoplasma (Fig. 6A). The increased
level of expression was equal to that observed for infection
with Toxoplasma alone. In spite of the increased expression of
mRNA, all nonvaccinated mice died by day 7 postinfection. A
progressive decline in mRNA for IFN-g after day 14 postchal-
lenge was observed for the vaccinated and challenged group.
A dramatic difference in the expression of mRNA for IL-10
was observed following vaccination (Fig. 6B). Mice infected
with Toxoplasma alone expressed almost 70 times the back-
ground levels of mRNA for IL-10 shortly before their deaths
by day 7 postinfection. In contrast, vaccinated mice demon-
strated only a moderate rise in the expression of mRNA for
IL-10 following Toxoplasma challenge. IL-10 expression levels
returned to baseline by day 14 postchallenge.
To determine the specificity of the cytokine response, the
level of IFN-g produced by the CD81 T cells in response to the
parasite antigen was determined. For this study, the spleno-
cytes from mice were isolated in a CD81 T-cell population
postvaccination. The CD81 T cells were cultured in vitro in the
presence of irradiated antigen-presenting cells and parasite
antigen. The level of cytokine protein in the supernatant was
measured. As shown in Table 2, CD81 T cells from Neospora-
infected mice produced significant quantities of IFN-g in re-
sponse to both the Toxoplasma and Neospora antigens, al-
though there was a significantly greater quantity of IFN-g
produced in response to Neospora antigen.
Identification of cross-reactive antigen epitopes. The obser-
vations above indicated that Neospora vaccination was able to
protect against challenge with Toxoplasma. A T-cell Western
blot analysis was performed to determine if there were T-cell
antigens that were cross-reactive between the two parasite
FIG. 4. Lymphoproliferation of CD81 T cells. Splenocytes from Neospora-
vaccinated mice were isolated postvaccination. Spleen cells were pooled, and
CD81 T cells were isolated by magnetic bead separation (.95% purity as
determined by FACS). The cells were cultured in 96-well plates (105 cells/well)
and stimulated with mitogen or antigen plus irradiated feeder cells. At 72 (mi-
togen) or 96 h (antigen) postincubation DNA synthesis was measured by thymi-
dine incorporation. unst, unstimulated; ConA, stimulated with Con A; Toxo,
stimulated with Toxoplasma antigen; Neo, stimulated with Neospora antigen.
FIG. 5. Adoptive transfer of Toxoplasma antigen-responsive CD81 T cells.
CD81 T cells were isolated by magnetic bead separation from the splenocytes of
Neospora-vaccinated mice (Neo). The purified CD81 T cells were 95% pure as
determined by FACS and were cultured in vitro in the presence of the Toxo-
plasma antigen. Five days postculture, the proliferating CD81 T cells were
recovered (.98% purity as determined by FACS) and adoptively transferred
(107 cells) via tail vein injection into naive mice. Mice were challenged with 104
PLK strain tachyzoites.
FIG. 6. Cytokine mRNA expression in N. caninum-infected and T. gondii-
challenged mice. Mice were infected with N. caninum, followed by challenge with
T. gondii as described in Materials and Methods. The splenocytes were harvested
at various time points starting at day 3 postchallenge. The spleen cells from three
mice were pooled for each time point, and mRNA expression for IFN-g (A) and
IL-10 (B) was assayed by reverse transcription-PCR. The differences in the
transcriptional levels for all the genes are expressed relative to those for genes of
mice treated with saline (defined as 1) as previously described (16, 17). The
cDNA concentration examined at each time point was standardized to the
hypoxanthine phosphoribosyltransferase mRNA levels (data not shown).
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strains. Neospora and Toxoplasma lysates were separated by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis and
transferred to nitrocellulose paper. CD81 T cells that had been
isolated from Neospora-vaccinated mice were incubated with
the various parasite antigens. These CD81 T cells proliferate
in response to both Toxoplasma (Fig. 7A) and Neospora (Fig.
7B) lysates. There are Neospora antigen-reactive T cells in both
the 30- and 18-kDa regions on the Western blot. Of note is the
highly reactive epitope to the Neospora antigen at approxi-
mately 30 kDa, although there is no clearly defined band on the
antibody-reactive blot, as shown in Fig. 8.
The antigen lanes were reacted with anti-Neospora poly-
clonal IgG that had been isolated from the serum fraction of
immunized rabbits. As shown in Fig. 8, there were multiple
antigenic bands in each of the parasite preparations that were
of both similar and divergent molecular weights. The most
striking observation is the reactivity of the anti-Neospora anti-
body with the Toxoplasma lysate, in particular the reactivity
with two bands in that lane of approximately 30 and 18 kDa.
Neither of these bands appears as strongly reactive in the
Neospora antigen lane. Similar observations were made when
the sera from Neospora-infected mice were reacted with either
the Toxoplasma or Neospora antigens.
DISCUSSION
In this report we demonstrate that N. caninum can mediate
CD81 T-cell immunity against acute T. gondii infection in an
experimental murine model. N. caninum was first isolated from
dogs (20) and infects a wide range of mammals. The develop-
ment of infection in mice appears to be genetically restricted in
that some mouse strains are more susceptible to infection of
the central nervous system (18). Recent studies at our labora-
tory demonstrate that A/J mice are highly resistant to infection
with this parasite (17). In the A/J mouse, Neospora infection
was limited to a few scattered inflammatory foci of zoites in the
brain following acute infection. Because of the strong innate
resistance to Neospora infection in mice and the morphological
similarity of N. caninum to T. gondii, we evaluated whether this
parasite could protect against acute Toxoplasma infection.
Our studies demonstrate that vaccination with Neospora pre-
vents death following a lethal challenge with Toxoplasma. This
observation differs from those in studies by Lindsay and co-
workers, who reported that N. caninum was not protective
against Toxoplasma challenge (17a). In that study, the viru-
lence of the challenge strain and the number of parasites used
for challenge differed from those of ours. The RH strain (type
1) (10) of T. gondii used by Lindsay and coworkers is lethal
with as few as 10 parasites. In our study, vaccinated mice were
completely protected against challenge with the less-virulent
PLK strain (type II) even when 1,000 times more parasites
were used in the challenge. These mice were resistant to Tox-
oplasma challenge provided the vaccinating dose of N. cani-
num did not fall below 5 3 105 organisms. It appears that
protection is dependent on the strain of Toxoplasma used for
challenge.
The protective response elicited by Neospora is mediated by
FIG. 7. T-cell Western analysis of splenocytes from Neospora-vaccinated mice. Toxoplasma (A) and Neospora (B) lysates were separated by Western blotting as
described in Materials and Methods. Splenocytes were isolated from Neospora-vaccinated mice, and the CD81 population (95% pure) was incubated in the presence
of the parasite antigen plus irradiated feeder cells. Lymphoproliferation in response to the parasite extract was determined by measuring thymidine incorporation.
Molecular weights are in thousands. Error bars indicate SD.
TABLE 2. IFN-g production by CD81 T cells from
N. caninum-infected micea
Treatment
Amt of IFN-gb (pg/ml) produced in:
Naive mice N. caninum-infected mice
Unstimulated N.D.c 5.85 6 1.4
NLA N.D. 1,998 6 210
TLA 6.7 6 2.1 1,166 6 43
a Mice were infected with 106 tachyzoites of N. caninum. Purified CD81 T cells
were stimulated with 15 mg of either Neospora lysate (NLA) or Toxoplasma lysate
(TLA) per ml, and the supernatant was assayed for IFN-g by enzyme-linked
immunosorbent assay.
b Values are means 6 SD.
c N.D., not detected.
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CD81 T cells. Both Neospora and Toxoplasma can stimulate
the expansion of the CD81 T-cell subset, whereas the CD41
T-cell subset does not expand. The CD81 T cells proliferate in
vitro in response to either parasite antigen. Adoptive transfer
of CD81 T cells but not CD82 T cells into a naive host protects
against Toxoplasma challenge. Although cells from other im-
mune compartments, most notably NK cells, are involved in
innate resistance, the isolation of antigen-reactive and protec-
tive CD81 T cells would suggest that this immunity is an
antigen-specific condition.
Although Toxoplasma and Neospora may contain antigeni-
cally distinct T-cell epitopes (4), we have previously observed
antigen cross-reactivity between the two parasites (17). The
Western blot analysis performed with both Toxoplasma and
Neospora antigens that were reacted with the IgG fractions of
anti-Neospora sera demonstrates a number of shared bands,
principally between 43 and 97 kDa. Of particular note are the
bands in the Toxoplasma antigen lane that are not in the
Neospora antigen lane and that react with the Neospora anti-
body. These bands are most notable at 30 and 18 kDa. Cross-
reactive epitopes with similar sequence homology between
Neospora and Toxoplasma may exist. Although earlier studies
have suggested that these parasites belong to different genera,
it is possible that there are shared immunoreactive epitopes.
Recent unpublished observations have suggested that the ma-
jor surface antigen of Toxoplasma (SAG1) has substantial se-
quence homology with a number of additional surface antigens
of this parasite (3). Although the genes for these SAG1 ho-
mologs are probably distinct, it is possible that some of the
expressed amino acid sequences represent T-cell epitopes
common to the two organisms.
Splenocytes from Neospora-infected mice show significant
proliferation in response to a Toxoplasma lysate. Of particular
significance is the expansion of the CD81 T-cell subset from
Neospora-vaccinated mice in response to the presence of the
Toxoplasma antigen. The T-cell Western blot assay demon-
strates that there are a number of parasite antigens of various
molecular masses (15 to 50 kDa) that are reactive to the CD81
T cells. There is reactivity in the regions of 30 and 18kDa with
both parasite preparations. Analyses of the relationship be-
tween different viruses and viral proteins have shown that
cross-reactivity between heterologous T-cell epitopes does ex-
ist (22). Prior immunity to one virus could modulate future
primary responses to another virus. A similar mechanism may
be responsible for the immunity in our system, whereby an
increase in the CD81 T-cell activity directed at Neospora may
provide for enhanced protection against Toxoplasma. This may
account for the high level of activity in the same approximate
molecular mass range as determined by T-cell Western blot
analysis. These Neospora-primed CD81 T cells may be recog-
nizing homologs and reactive T-cell epitopes of Toxoplasma, in
particular the SAG1-related sequences observed by Boothroyd
(3). The importance of CD81 T cells in host immunity to
Neospora is consistent with the observations for Toxoplasma (9,
15, 23). Isolation and characterization of these cross-reactive
antigens may provide a novel strategy for immunization against
infection with Toxoplasma.
The importance of the cytokine response during dual infec-
tion with these two parasites must also be considered. A rise in
IL-10 production at day 7 after Toxoplasma challenge has been
reported and is probably involved in Toxoplasma-induced im-
munosuppression of the host (16). It has been further pro-
posed that the production of IL-10 is required to prevent
immune hyperactivity and that the high levels of IL-10 are a
response to pathogenic levels of IFN-g (7). A severalfold in-
crease in the expression of IL-10 does occur at day 10 after
Neospora vaccination (17). In this report, we demonstrate that
during dual infection a marked reversal in the production of
Toxoplasma-mediated IL-10 expression occurs. The signifi-
cance of this reduced expression of IL-10 is uncertain, al-
though it may be related to altering Toxoplasma-mediated im-
munosuppression (16). In contrast, vaccination with Neospora
stimulates an exuberant IL-12 response (17). When Neospora-
vaccinated mice are depleted of IL-12 with antibody, the level
of mRNA for IL-10 rises 100-fold. It is possible that the exu-
berant IL-12 response observed following Neospora vaccina-
tion regulates the expression of IL-10 after Toxoplasma chal-
lenge.
It is well established that IFN-g is essential for survival
against infection with Toxoplasma. Similarly, host protection
against Neospora also appears to be dependent on IFN-g (17).
During murine T. gondii infection, CD81 T cells are an impor-
tant source of IFN-g. These studies show that following stim-
ulation with parasite antigen, the proliferating CD81 T cells
obtained from Neospora-vaccinated mice produce a significant
quantity of IFN-g. These IFN-g-producing CD81 T cells are
probably involved in the establishment of long-term immunity
to this parasite since they are apparent for at least 1 month
postvaccination.
FIG. 8. Western blot analysis of parasite antigens reactive with the anti-
Neospora antibody. Toxoplasma and Neospora lysates were separated by Western
blotting. The transferred proteins were reacted with a pooled sample of rabbit
anti-Neospora IgG. Reactivity was determined with peroxidase-labeled goat anti-
rabbit IgG. The control lanes that included human foreskin fibroblasts and
peroxidase-labeled anti-rabbit IgG alone were nonreactive (data not shown).
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